PMID: 11994102

Eaton TE, Weiner Miller P, Garrett JE, Cutting GR
Cystic fibrosis transmembrane conductance regulator gene mutations: do they play a role in the aetiology of allergic bronchopulmonary aspergillosis?
Clin Exp Allergy. 2002 May;32(5):756-61., [PubMed]
Sentences
No. Mutations Sentence Comment
5 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11994102:5:102
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11994102:5:233
status: NEW
view ABCC7 p.Arg117His details
Results Four (12.9%) ABPA patients were found to be carriers of a CF mutation (ÁF508 n ˆ 3, R117H n ˆ 1), one (4.3%) asthmatic SPT positive to Af without ABPA (ÁF508), and one (3.6%) asthmatic SPT negative to Af (R117H). Login to comment
53 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11994102:53:262
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11994102:53:184
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 11994102:53:230
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 11994102:53:191
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 11994102:53:269
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 11994102:53:216
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 11994102:53:223
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 11994102:53:283
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 11994102:53:248
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 11994102:53:276
status: NEW
view ABCC7 p.Arg560Thr details
Cystic ®brosis mutation analysis Genomic DNA samples were screened for 16 CF mutations utilizing allelic-speci®c oligonucleotide (ASO) hybridization; ÁF508, ÁI507, R117H, W1282X, 621 ‡ IG3T, R334W, R347P, A455E, 1717-IG3A, G542X, 5549N, G551D, R553X, R560T, N1303K and 3849 ‡ 10KC3T. Login to comment
55 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 11994102:55:92
status: NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Ile506Val
X
ABCC7 p.Ile506Val 11994102:55:99
status: NEW
view ABCC7 p.Ile506Val details
ABCC7 p.Ile507Val
X
ABCC7 p.Ile507Val 11994102:55:109
status: NEW
view ABCC7 p.Ile507Val details
Patients were also screened for CFTR variants in intron 8 (5T, 7T and 9T) and polymorphisms F508C, I506V and I507V. Login to comment
77 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11994102:77:86
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11994102:77:302
status: NEW
view ABCC7 p.Arg117His details
Four (12.9%) ABPA patients had a CFTR mutation identi®ed (ÁF508 n ˆ 3, R117H n ˆ 1), which was not signi®cantly different to either group of asthmatics without ABPA; one (4.3%) asthmatic SPT positive to Af without ABPA (ÁF508) and one (3.6%) asthmatic SPT negative to Af (R117H) (P > 0.35). Login to comment
80 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11994102:80:4
status: NEW
view ABCC7 p.Arg117His details
The R117H mutation can be associated with either the 5T or 7T variant of the polythymidine tract in intron 8 of the CF gene [33]. Login to comment
89 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11994102:89:17
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11994102:89:74
status: NEW
view ABCC7 p.Arg117His details
patient carrying R117H was homozygous for the 7T variant, indicating that R117H was associated with 7T in this patient. Login to comment
90 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11994102:90:18
status: NEW
view ABCC7 p.Arg117His details
The status of the R117H mutation in the ABPA patient could not be established because the patient carried the 5T and 7T variants. Login to comment
117 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11994102:117:320
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11994102:117:349
status: NEW
view ABCC7 p.Arg117His details
Group comparison of CFTR mutations Asthma SPT-positive Af with ABPA Asthma SPT-positive Af without ABPA Asthma SPT-negative Af n ˆ 31 n ˆ 23 n ˆ 28 Presence of CFTR mutations n (%) 4 (12.9%)* 1 (4.3%) 1 (3.6%) (exact CI) (3.68, 29.8) (0.11, 21.9) (0.09, 18.3) Type of CFTR mutation ÁF508, n ˆ 3 R117H, n ˆ 1 ÁF508 R117H *No evidence of a difference in proportions in the three groups, P > 0.35. function as a disease modi®er, potentially increasing disease severity. Login to comment